3/19
06:20 am
gyre
Gyre Therapeutics (GYRE) was downgraded by Zacks Research from "hold" to "strong sell".
Medium
Report
Gyre Therapeutics (GYRE) was downgraded by Zacks Research from "hold" to "strong sell".
3/17
08:29 am
gyre
Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment [Yahoo! Finance]
Low
Report
Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment [Yahoo! Finance]
3/17
07:00 am
gyre
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
Low
Report
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
3/12
06:28 am
gyre
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/12
06:12 am
gyre
Gyre Therapeutics GAAP EPS of -$0.02 misses by $0.09, revenue of $37.2M beats by $1.76M [Seeking Alpha]
Low
Report
Gyre Therapeutics GAAP EPS of -$0.02 misses by $0.09, revenue of $37.2M beats by $1.76M [Seeking Alpha]
3/12
06:00 am
gyre
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Low
Report
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/2
08:28 am
gyre
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline [Yahoo! Finance]
High
Report
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline [Yahoo! Finance]
3/2
08:00 am
gyre
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline
High
Report
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline
3/12/2026
06:00 am
gyre
gyre therapeutics, inc.
MISS
Report
-1.6%
gyre therapeutics, inc.
11/7/2025
06:00 am
gyre
gyre therapeutics, inc.
MISS
Report
-3.6%
gyre therapeutics, inc.
8/11/2025
04:01 pm
gyre
gyre therapeutics, inc.
MISS
Report
-4.2%
gyre therapeutics, inc.
5/9/2025
06:00 am
gyre
gyre therapeutics, inc.
MISS
Report
2.3%
gyre therapeutics, inc.
3/13
04:32 pm
gyre
Form 10-K GYRE THERAPEUTICS, INC. For: Dec 31
Low
Report
Form 10-K GYRE THERAPEUTICS, INC. For: Dec 31
3/12
06:31 am
gyre
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 10
Low
Report
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 10
3/12
06:04 am
gyre
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 12
Low
Report
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 12
3/2
09:24 am
gyre
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 02
Medium
Report
Form 8-K GYRE THERAPEUTICS, INC. For: Mar 02
1/9
04:01 pm
gyre
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Zhang Ping
Medium
Report
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Zhang Ping
1/9
04:01 pm
gyre
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Chen Ruoyu
Medium
Report
Form 4 GYRE THERAPEUTICS, INC. For: Jan 07 Filed by: Chen Ruoyu
1/5
07:06 am
gyre
Form 8-K GYRE THERAPEUTICS, INC. For: Jan 05
High
Report
Form 8-K GYRE THERAPEUTICS, INC. For: Jan 05
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register